Ep200: Richard Pops Reflects on a 35-Year Career in Biotech

The Long Run with Luke Timmerman by The Long Run with Luke Timmerman

May 5, 202601:13:31Science & Medicine

Alkermes CEO Richard Pops reflects on his 35-year career leading the company and its new opportunity in orexin biology for sleep disorders and more neurological conditions.

Related Episodes

Continue listening to more episodes from The Long Run with Luke Timmerman.

Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets

Sep 9, 2026 - 01:36:12

Mathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide mole...

Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus

Aug 25, 2026 - 01:07:17

Gary Nabel, CEO of Weston, Mass.-based ModeX Therapeutics, on developing a vaccine for Epstein-Barr Virus...

Ep207: Jason Coloma on Genetic Medicines for Kidney Diseases

Aug 11, 2026 - 01:17:31

Jason Coloma, CEO of South San Francisco-based Maze Therapeutics, on developing small molecule drugs base...

Ep206: Lyn Baranowski on Inhalable Medicines for Severe Lung Diseases

Jul 28, 2026 - 01:07:17

Lyn Baranowski, CEO of Boston-based Avalyn Pharma, on developing inhalable medicines for severe lung dise...

Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With

Jul 14, 2026 - 01:08:18

Heather Turner, CEO of New York-based LB Pharma, on developing a new schizophrenia drug designed to bette...

Ep204: Troy Wilson on Precision Cancer Drugs and Combos

Jun 30, 2026 - 01:07:27

Troy Wilson, CEO of San Diego-based Kura Oncology, on his career in biotech and developing targeted cance...

Ep203: Sri Kosuri on Small Molecule Correctors of Disease

Jun 16, 2026 - 01:11:43

Sri Kosuri, co-founder and CEO of Emeryville, Calif.-based Octant Bio, on small molecules designed to cor...

Ep202: Becky Pferdehirt on Reimagining Science for the AI Era

Jun 2, 2026 - 01:08:12

Becky Pferdehirt, CEO of Emeryville, CA-based Radial, the life sciences unit of Astera Institute, on reim...